Regadenoson Injection
Product Images NDC 55150-443

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 55150-443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label Principal Display Panel 0.4 mg Per 5 mL (0.08 mg/ml) (Syringe Label)

Regadenoson Injection is a prescription drug used for pharmacologic stress only during a medical procedure. It is only for intravenous use and contains 0.4mg per 5 mL, with a concentration of 0.08 mg/m. The drug comes in a 5 mL single-dose prefilled syringe, and any unused portion must be discarded. The manufacturer, Eugia US LLC, is based in E. Windsor, NJ 08520. The product is identified by the NDC 55150-443-01, and the code TS/DRUGS/13/2010 and P1428454.*

FDA Label Image

Package Label Principal Display Panel 0.4 mg Per 5 mL (0.08 mg/ml) (Syringe-Carton)

This text appears to be a mix of technical information related to a medication, including dosing instructions and storage recommendations, as well as some miscellaneous characters that do not form a coherent meaning. Some of the text is also cut off, making it difficult to fully understand.*

FDA Label Image

Ragadenoson-structure (Regadenoson Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.